Skip to content

A real-world study of the pognostic factors of reperfusion therapy in acute ischemic stroke

A real-world study of the pognostic factors of reperfusion therapy in acute ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064301
Enrollment
Unknown
Registered
2022-10-02
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Sponsors

Zhaoqing First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. All patients received reperfusion therapy (intravenous thrombolysis or thrombectomy; 3. With computed brain tomography and magnetic resonance imaging scans during hospitalization; 4. Complete follow-up data were available through the electronic medical record system.

Exclusion criteria

Exclusion criteria: 1. Combined systemic inflammatory disease, malignancy, history of hematologic disease, severe hepatitis, renal dysfunction, or history of cardiac dysfunction; 2. Patients lacking follow-up information and the essential clinical baseline information to complete the follow-up analysis.

Design outcomes

Primary

MeasureTime frame
3 months MRs;

Secondary

MeasureTime frame
Early neurological deterioration;Symptomatic intracranial hemorrhage;

Countries

China

Contacts

Public ContactWanchun Yin

Zhaoqing First People's Hospital

yinwch007@163.com+86 18902368599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026